drugset / Trial / NCT02267512
Efficacy and Safety of Two Anti-T-lymphocyte Immune Globulin (ATG-F) Induction Regimens in Anew Kidney Transplant Patients
RandomizedParallel-groupOpen-labelPrevention
Summary
To investigate the efficacy and safety of ATG-F induction regimen using a single dose of ATG-F compared with a five-day dose regimen of ATG-F in anew kidney transplant recipients.
Timeline
- Start
- 2012-07-31
- Primary completion
- 2015-12-31
- Completion
- 2015-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ATG-F | Protein / enzyme biologic | — | Intravenous |
Indications
No indication recorded.